Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 569

1.

Durability of pneumatic dilation monotherapy in treatment-naive achalasia patients.

Javed AT, Batte K, Khalaf M, Abdul-Hussein M, Elias PS, Castell DO.

BMC Gastroenterol. 2019 Nov 11;19(1):181. doi: 10.1186/s12876-019-1104-z.

2.

Randomized Trial of Medical versus Surgical Treatment for Refractory Heartburn.

Spechler SJ, Hunter JG, Jones KM, Lee R, Smith BR, Mashimo H, Sanchez VM, Dunbar KB, Pham TH, Murthy UK, Kim T, Jackson CS, Wallen JM, von Rosenvinge EC, Pearl JP, Laine L, Kim AW, Kaz AM, Tatum RP, Gellad ZF, Lagoo-Deenadayalan S, Rubenstein JH, Ghaferi AA, Lo WK, Fernando RS, Chan BS, Paski SC, Provenzale D, Castell DO, Lieberman D, Souza RF, Chey WD, Warren SR, Davis-Karim A, Melton SD, Genta RM, Serpi T, Biswas K, Huang GD.

N Engl J Med. 2019 Oct 17;381(16):1513-1523. doi: 10.1056/NEJMoa1811424.

PMID:
31618539
3.

Improving High-resolution Impedance Manometry Using Novel Viscous and Super-viscous Substrates in the Supine and Upright Positions: A Pilot Study.

Wong U, Person EB, Castell DO, von Rosenvinge E, Raufman JP, Xie G.

J Neurogastroenterol Motil. 2018 Oct 1;24(4):570-576. doi: 10.5056/jnm18010.

4.

Alternative therapies for GERD: a way to personalized antireflux surgery.

Rieder E, Riegler M, Simić AP, Skrobić OM, Bonavina L, Gurski R, Paireder M, Castell DO, Schoppmann SF.

Ann N Y Acad Sci. 2018 Dec;1434(1):360-369. doi: 10.1111/nyas.13851. Epub 2018 May 17.

PMID:
29774563
5.

Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel.

Yadlapati R, Vaezi MF, Vela MF, Spechler SJ, Shaheen NJ, Richter J, Lacy BE, Katzka D, Katz PO, Kahrilas PJ, Gyawali PC, Gerson L, Fass R, Castell DO, Craft J, Hillman L, Pandolfino JE.

Am J Gastroenterol. 2018 Jul;113(7):980-986. doi: 10.1038/s41395-018-0045-4. Epub 2018 Apr 24.

6.

Acid Control in Barrett's Esophagus: A Plea for Documentation.

Elias PS, Castell DO.

Am J Gastroenterol. 2018 Feb;113(2):307. doi: 10.1038/ajg.2017.418. No abstract available.

PMID:
29467537
7.

Manometric Subtypes of Ineffective Esophageal Motility.

Hiestand M, Abdel Jalil A, Castell DO.

Clin Transl Gastroenterol. 2017 Mar 9;8(3):e78. doi: 10.1038/ctg.2017.4.

8.

The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.

Johnson DA, Katz PO, Armstrong D, Cohen H, Delaney BC, Howden CW, Katelaris P, Tutuian RI, Castell DO.

Drugs. 2017 Apr;77(5):547-561. doi: 10.1007/s40265-017-0712-6. Review.

9.

The Role of Acid Suppression in Barrett's Esophagus.

Elias PS, Castell DO.

Am J Med. 2017 May;130(5):525-529. doi: 10.1016/j.amjmed.2016.12.032. Epub 2017 Feb 1. Review.

PMID:
28159599
10.

A System to Assess the Competency for Interpretation of Esophageal Manometry Identifies Variation in Learning Curves.

Yadlapati R, Keswani RN, Ciolino JD, Grande DP, Listernick ZI, Carlson DA, Castell DO, Dunbar KB, Gawron AJ, Gyawali CP, Katz PO, Katzka D, Lacy BE, Spechler SJ, Tatum R, Vela MF, Pandolfino JE.

Clin Gastroenterol Hepatol. 2017 Nov;15(11):1708-1714.e3. doi: 10.1016/j.cgh.2016.07.024. Epub 2016 Jul 27.

11.

Association of Acute Gastroesophageal Reflux Disease With Esophageal Histologic Changes.

Dunbar KB, Agoston AT, Odze RD, Huo X, Pham TH, Cipher DJ, Castell DO, Genta RM, Souza RF, Spechler SJ.

JAMA. 2016 May 17;315(19):2104-12. doi: 10.1001/jama.2016.5657.

12.

Utility of Esophagram versus High-Resolution Manometry in the Detection of Esophageal Dysmotility.

O'Rourke AK, Lazar A, Murphy B, Castell DO, Martin-Harris B.

Otolaryngol Head Neck Surg. 2016 May;154(5):888-91. doi: 10.1177/0194599816629379. Epub 2016 Feb 23.

13.

Ineffective Esophageal Motility (IEM): the Old-New Frontier in Esophagology.

Abdel Jalil AA, Castell DO.

Curr Gastroenterol Rep. 2016 Jan;18(1):1. doi: 10.1007/s11894-015-0472-y. Review.

PMID:
26685862
14.

Achalasia: All Sticks in One Bundle!

Abdel Jalil A, Tutuian R, Castell DO.

Clin Gastroenterol Hepatol. 2016 May;14(5):e49. doi: 10.1016/j.cgh.2015.10.031. Epub 2015 Nov 10. No abstract available.

PMID:
26546754
15.

Identification of Quality Measures for Performance of and Interpretation of Data From Esophageal Manometry.

Yadlapati R, Gawron AJ, Keswani RN, Bilimoria K, Castell DO, Dunbar KB, Gyawali CP, Jobe BA, Katz PO, Katzka DA, Lacy BE, Massey BT, Richter JE, Schnoll-Sussman F, Spechler SJ, Tatum R, Vela MF, Pandolfino JE.

Clin Gastroenterol Hepatol. 2016 Apr;14(4):526-534.e1. doi: 10.1016/j.cgh.2015.10.006. Epub 2015 Oct 20.

16.

Minor Motility Defects? Perhaps, but What About a True "Functional" Assessment?

Castell DO, Tutuian R.

Clin Gastroenterol Hepatol. 2016 Mar;14(3):481. doi: 10.1016/j.cgh.2015.09.034. Epub 2015 Oct 31. No abstract available.

PMID:
26453954
17.

Characteristics of Consecutive Esophageal Motility Diagnoses After a Decade of Change.

Boland K, Abdul-Hussein M, Tutuian R, Castell DO.

J Clin Gastroenterol. 2016 Apr;50(4):301-6. doi: 10.1097/MCG.0000000000000402.

18.

Cough and Throat Clearing: Atypical GERD Symptoms or Not GERD at All?

Abdul-Hussein M, Freeman J, Castell DO.

J Clin Gastroenterol. 2016 May-Jun;50(5):e50-4. doi: 10.1097/MCG.0000000000000384.

PMID:
26196474
19.

A Novel Sleep Positioning Device Reduces Gastroesophageal Reflux: A Randomized Controlled Trial.

Person E, Rife C, Freeman J, Clark A, Castell DO.

J Clin Gastroenterol. 2015 Sep;49(8):655-9. doi: 10.1097/MCG.0000000000000359.

PMID:
26053170
20.

Diagnosis of Esophageal Motility Disorders: Esophageal Pressure Topography vs. Conventional Line Tracing.

Carlson DA, Ravi K, Kahrilas PJ, Gyawali CP, Bredenoord AJ, Castell DO, Spechler SJ, Halland M, Kanuri N, Katzka DA, Leggett CL, Roman S, Saenz JB, Sayuk GS, Wong AC, Yadlapati R, Ciolino JD, Fox MR, Pandolfino JE.

Am J Gastroenterol. 2015 Jul;110(7):967-77; quiz 978. doi: 10.1038/ajg.2015.159. Epub 2015 Jun 2.

21.

Approach to the patient with dysphagia.

Abdel Jalil AA, Katzka DA, Castell DO.

Am J Med. 2015 Oct;128(10):1138.e17-23. doi: 10.1016/j.amjmed.2015.04.026. Epub 2015 May 23. Review.

PMID:
26007674
22.

Monitoring for GE Reflux: Is Normal the New Normal?

Abdul-Hussein M, Castell DO.

Dig Dis Sci. 2015 May;60(5):1118-9. doi: 10.1007/s10620-014-3442-6. No abstract available.

PMID:
25421560
23.

Multiple good options are available for achalasia management.

Clayton SB, Castell DO.

J Clin Gastroenterol. 2015 Mar;49(3):194-8. doi: 10.1097/MCG.0000000000000107.

PMID:
24618506
24.

Viscous impedance is an important indicator of abnormal esophageal motility.

Clayton SB, Rife C, Kalbfleisch JH, Castell DO.

Neurogastroenterol Motil. 2013 Jul;25(7):563-e455. doi: 10.1111/nmo.12117. Epub 2013 Apr 29.

PMID:
23621545
25.

Motility: Achalasia subtyping directs therapy.

Castell DO.

Nat Rev Gastroenterol Hepatol. 2013 Apr;10(4):202-3. doi: 10.1038/nrgastro.2013.40. Epub 2013 Mar 12. No abstract available.

PMID:
23478382
26.

Laryngopharyngeal reflux: to be or not to be?

Castell DO.

J Clin Gastroenterol. 2013 Mar;47(3):193-4. doi: 10.1097/MCG.0b013e318279ac07. No abstract available.

PMID:
23391867
28.

Swallowing activity assessed by ambulatory impedance-pH monitoring predicts awake and asleep periods at night.

Pohl D, Arevalo F, Singh E, Freeman J, Tutuian R, Castell DO.

Dig Dis Sci. 2013 Apr;58(4):1049-53. doi: 10.1007/s10620-012-2474-z. Epub 2012 Nov 18.

29.

Interobserver variability in esophageal body measurements with high-resolution manometry among new physician users.

Singh ER, Rife C, Clayton S, Naas P, Nietert P, Castell DO.

J Clin Gastroenterol. 2013 Feb;47(2):e12-6. doi: 10.1097/MCG.0b013e3182557099.

30.

Characterization of patients with low baseline impedance on multichannel intraluminal impedance-pH reflux testing.

Heard R, Castell J, Castell DO, Pohl D.

J Clin Gastroenterol. 2012 Aug;46(7):e55-7. doi: 10.1097/MCG.0b013e318247c319.

PMID:
22476039
31.

Impedance pH confirms the relationship between GERD and BMI.

Hajar N, Castell DO, Ghomrawi H, Rackett R, Hila A.

Dig Dis Sci. 2012 Jul;57(7):1875-9. doi: 10.1007/s10620-012-2131-6. Epub 2012 Mar 27.

PMID:
22451118
32.

In the diagnosis of achalasia, "classic" might be "atypical".

Castell DO.

Clin Gastroenterol Hepatol. 2012 Jul;10(7):821-2. doi: 10.1016/j.cgh.2012.01.027. Epub 2012 Feb 20. No abstract available.

PMID:
22361278
33.

Twice-daily proton pump inhibitor therapy does not decrease the frequency of reflux episodes during nocturnal recumbency in patients with refractory GERD: analysis of 200 patients using multichannel intraluminal impedance-pH testing.

Clayton SB, Rife CC, Singh ER, Kalbfleisch JH, Castell DO.

Dis Esophagus. 2012 Nov-Dec;25(8):682-6. doi: 10.1111/j.1442-2050.2011.01310.x. Epub 2012 Jan 31.

PMID:
22292567
34.

Extraesophageal gastroesophageal reflux disease (GERD) symptoms are not more frequently associated with proximal esophageal reflux than typical GERD symptoms.

Roberts JR, Aravapalli A, Pohl D, Freeman J, Castell DO.

Dis Esophagus. 2012 Nov-Dec;25(8):678-81. doi: 10.1111/j.1442-2050.2011.01305.x. Epub 2012 Jan 13.

PMID:
22243631
35.

The evolution of achalasia.

Castell DO.

Dig Dis Sci. 2012 Mar;57(3):597-8. doi: 10.1007/s10620-011-2011-5. Epub 2011 Dec 20. No abstract available.

PMID:
22183822
36.

Pneumatic dilation for achalasia--the way forward: authors' reply.

Katzka DA, Castell DO.

Aliment Pharmacol Ther. 2011 Nov;34(10):1246-7. doi: 10.1111/j.1365-2036.2011.04859.x. No abstract available.

37.

Swallow evaluation during multichannel intraluminal impedance and pH: an alternate method to assess esophageal transit.

Hila A, Chowdhury N, Hajar N, Castell DO.

J Clin Gastroenterol. 2011 Nov-Dec;45(10):862-6. doi: 10.1097/MCG.0b013e31822a2c61.

PMID:
21857530
38.

Review article: an analysis of the efficacy, perforation rates and methods used in pneumatic dilation for achalasia.

Katzka DA, Castell DO.

Aliment Pharmacol Ther. 2011 Oct;34(8):832-9. doi: 10.1111/j.1365-2036.2011.04816.x. Epub 2011 Aug 17. Review.

39.

Academic mentoring: a 40-year adventure.

Castell DO.

Am J Gastroenterol. 2011 May;106(5):820-2. doi: 10.1038/ajg.2010.482. Epub 2011 Apr 19.

PMID:
21502997
40.

Review article: reflux and its consequences--the laryngeal, pulmonary and oesophageal manifestations. Conference held in conjunction with the 9th International Symposium on Human Pepsin (ISHP) Kingston-upon-Hull, UK, 21-23 April 2010.

Pearson JP, Parikh S, Orlando RC, Johnston N, Allen J, Tinling SP, Johnston N, Belafsky P, Arevalo LF, Sharma N, Castell DO, Fox M, Harding SM, Morice AH, Watson MG, Shields MD, Bateman N, McCallion WA, van Wijk MP, Wenzl TG, Karkos PD, Belafsky PC.

Aliment Pharmacol Ther. 2011 Apr;33 Suppl 1:1-71. doi: 10.1111/j.1365-2036.2011.04581.x. Review.

41.

High resolution esophageal manometry: devils and dinosaurs.

Castell DO.

Neurogastroenterol Motil. 2010 Jun;22(6):600-1. doi: 10.1111/j.1365-2982.2010.01499.x. Epub 2010 Apr 8. No abstract available.

PMID:
20377784
42.

Neural autoantibody profile of primary achalasia.

Kraichely RE, Farrugia G, Pittock SJ, Castell DO, Lennon VA.

Dig Dis Sci. 2010 Feb;55(2):307-11. doi: 10.1007/s10620-009-0838-9. Epub 2009 Jun 5.

43.

Comparison of reflux frequency during prolonged multichannel intraluminal impedance and pH monitoring on and off acid suppression therapy.

Blonski W, Vela MF, Castell DO.

J Clin Gastroenterol. 2009 Oct;43(9):816-20. doi: 10.1097/MCG.0b013e318194592b.

PMID:
19398927
44.

Symptoms with acid and nonacid reflux may be produced by different mechanisms.

Agrawal A, Roberts J, Sharma N, Tutuian R, Vela M, Castell DO.

Dis Esophagus. 2009;22(5):467-70. doi: 10.1111/j.1442-2050.2009.00940.x. Epub 2009 Feb 13.

PMID:
19222535
45.

Further comment on proton pump inhibitor failures.

Sharma N, Castell DO.

Clin Gastroenterol Hepatol. 2009 Mar;7(3):363. doi: 10.1016/j.cgh.2008.07.022. Epub 2008 Aug 5. No abstract available.

PMID:
19186217
46.

The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers.

Blonski W, Vela MF, Freeman J, Sharma N, Castell DO.

J Clin Gastroenterol. 2009 Mar;43(3):253-60. doi: 10.1097/MCG.0b013e318167b89d.

PMID:
18987553
47.

High resolution manometry: a word of caution.

Castell DO.

Am J Gastroenterol. 2008 Oct;103(10):2657-8. doi: 10.1111/j.1572-0241.2008.02074_8.x. No abstract available.

PMID:
18855865
48.

MBS measurement tool for swallow impairment--MBSImp: establishing a standard.

Martin-Harris B, Brodsky MB, Michel Y, Castell DO, Schleicher M, Sandidge J, Maxwell R, Blair J.

Dysphagia. 2008 Dec;23(4):392-405. doi: 10.1007/s00455-008-9185-9. Epub 2008 Oct 15.

49.

Characteristics of the esophageal low-pressure zone in healthy volunteers and patients with esophageal symptoms: assessment by high-resolution manometry.

Pohl D, Ribolsi M, Savarino E, Frühauf H, Fried M, Castell DO, Tutuian R.

Am J Gastroenterol. 2008 Oct;103(10):2544-9. doi: 10.1111/j.1572-0241.2008.02062.x. Epub 2008 Aug 5.

50.

Reflux testing in the 21st century: is there a role for pH only?

Castell DO.

Clin Gastroenterol Hepatol. 2008 Aug;6(8):840-1. doi: 10.1016/j.cgh.2008.04.007. Epub 2008 Jun 27. Review. No abstract available. Erratum in: Clin Gastroenterol Hepatol. 2008 Sep;6(9):1062.

PMID:
18585975

Supplemental Content

Loading ...
Support Center